IIRC, the initial customer for RAP will be telehealth companies....

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 105 Last

Share
Profile

Follow
LeeKing

5,885 Posts.

226

17/05/16

08:57

Post #: 17785071
Share

Originally posted by gsad1000 ↑

You are 100% correct, doctors may or may not use the ResApp and many initially won't due to the health administration industry being so backward.

But the factor you must consider is the health consumer and doctor google. The power in the doctor-patient relationship is moving toward the patient and has been for a while. Doctor won't use the app but the patient will before seeing the doctor.

Expand

IIRC, the initial customer for RAP will be telehealth companies. But if you mean that consumers will pressure the telehealth companies to adopt it, then I agree.

Originally posted by gedck ↑

And perhaps also another "potential" perspective to consider:
(i) Patient is presumed clear of infection from initial consultation (tele-health or in person) based on other products / existing approaches.
(ii) Condition of the patient deteriorates and they end up in an ER.
(ii) Doctor in the ER then rapidly diagnoses respiratory infection using ResApp and proper and prompt treatment is given (as expanding and implementing ResApp in emergency room settings was one of the many reasons for the recent CR...).
(iv) Medical industry (and consumers) realise (hopefully) the easiness and effectiveness of ResApp as a frontline diagnostic tool, thus avoiding timely, dangerous and avoidable misdiagnosis.
Just another perspective/scenario to consider....

Expand

Yes, if Resapp consistently outperforms other methods, then it will come to dominate the market.

I'm still gasping for the adult results.

RAP Price at posting: 25.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

EBR

EBR reaches review milestone for wireless cardiac pacing device

Results wrap: Austal, TPG Telecom and Downer

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

HLX

Helix investor makes partial takeover bid, proposing board changes

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

There are more pages in this discussion • 3 more messages in this thread...

First 105 Last

Add RAP (ASX) to my watchlist

IIRC, the initial customer for RAP will be telehealth companies....

Top Stories

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Lendlease sells off US east coast construction operations in latest global divestment push

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

EBR reaches review milestone for wireless cardiac pacing device

Results wrap: Austal, TPG Telecom and Downer

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Helix investor makes partial takeover bid, proposing board changes

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Featured News